======= PABPC4 ======= == Gene Information == * **Official Symbol**: PABPC4 * **Official Name**: poly(A) binding protein cytoplasmic 4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8761|8761]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q13310|Q13310]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PABPC4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PABPC4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603407|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Binds the poly(A) tail of mRNA. May be involved in cytoplasmic regulatory processes of mRNA metabolism. Can probably bind to cytoplasmic RNA sequences other than poly(A) in vivo (By similarity). {ECO:0000250}. |PABP| |RRM 1| |poly(C) RNA binding| |poly(A) binding| |poly(U) RNA binding| |myeloid cell development| |cytoplasmic stress granule| |mRNA 3-UTR binding| |ribonucleoprotein complex| |regulation of mRNA stability| |regulation of RNA stability| |regulation of mRNA catabolic process| |myeloid cell differentiation| |RNA catabolic process| |blood coagulation| |coagulation| |hemostasis| |regulation of mRNA metabolic process| |nucleobase-containing compound catabolic process| |translation| |peptide biosynthetic process| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |aromatic compound catabolic process| |wound healing| |organic cyclic compound catabolic process| |regulation of body fluid levels| |posttranscriptional regulation of gene expression| |amide biosynthetic process| |peptide metabolic process| |hemopoiesis| |response to wounding| |hematopoietic or lymphoid organ development| |immune system development| |cellular amide metabolic process| |regulation of cellular catabolic process| |RNA processing| |cellular macromolecule catabolic process| |regulation of catabolic process| |macromolecule catabolic process| |RNA binding| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |cell development| |RNA metabolic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |organic substance catabolic process| |cellular catabolic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-1.98| |[[:results:exp142|OICR-9429 10μM R03 exp142]]|-1.88| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|-1.75| |[[:results:exp212|Phenformin 20μM R05 exp212]]|1.77| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.81| |[[:results:exp469|CFI-400945 25μM R08 exp469]]|1.83| |[[:results:exp515|PU-H71 1μM R08 exp515]]|1.83| |[[:results:exp476|Dihydrosphingosine 8μM R08 exp476]]|1.98| |[[:results:exp17|DABN 20μM R00 exp17]]|2.24| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|1/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7254 * **Expression level (log2 read counts)**: 8.7 {{:chemogenomics:nalm6 dist.png?nolink |}}